Physician profile

Arun K Devakonda

Pulmonary Disease · Oklahoma City, OK

NPI 1083873848

$1,816.28

in general payments reported to CMS, 2019-2025

17 companies · $1,151 in 2025

The $1,151 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$832.55
Food and Beverage$741.06

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Olympus Corporation of The Americas $878.68 2025
Baxter Healthcare $218.67 2024-2025 Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System
Glaxosmithkline, LLC. $192.29 2022-2025 Nucala, Trelegy Ellipta
Insmed, INC. $161.19 2022-2025 Arikayce, Brinsupri
Astrazeneca Pharmaceuticals LP $54.65 2022-2025 Fasenra
Genzyme Corporation $46.16 2025
United Therapeutics Corporation $42.61 2024 Tyvaso
Electromed, INC. $36.97 2024 Smartvest
Regeneron Healthcare Solutions, INC. $33.25 2022
Csl Behring $27.30 2020
Boehringer Ingelheim Pharmaceuticals, INC. $25.31 2022
Mylan Specialty L.P. $22.60 2022
Fisher & Paykel Healthcare INC $19.21 2021
Novartis Pharmaceuticals Corporation $16.74 2021
Amgen INC. $15.50 2025 Tezspire
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Inogen, INC. $13.85 2023 Inogen One G5 Oxygen Concentrator - Bluetooth
Sunovion Pharmaceuticals INC. $11.30 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Arun K Devakonda

$1,816.28

in general payments reported 2019-2025

Years
2020-2025
Top company
Olympus Corporation of The Americas
Context
The $1,151 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/321361/arun-k-devakonda

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.